extracellular caspase-8 dependent apoptosis on hela cancer cells and mrc-5 normal cells by icd-85 (venom derived peptides)
Authors
abstract
background: our previous studies revealed an inhibitory effect of icd-85 (venom derived peptides) on mda-mb231 and hl-60 cell lines, through induction of apoptosis. the purpose of this study was to investigate apoptosis-induced mechanism on hela and mrc-5 cells by icd-85 through activation of caspase-8. methods: cell viability, cytosolic enzyme lactate dehydrogenase (ldh) and cell morphology were assessed under unexposed and icd-85 exposed conditions.caspase-8 activity was assayed by caspase-8 colorimetric assay kit. results: the results show that inhibitory concentration 50% (ic 50 ) value of icd-85 for hela cells at 24 h was estimated and found to be 25.32±2.15µg/ml. furthermore, treatment of hela cells with icd-85 at concentrations of 1.6×10 and 2.6×10µg/ml did not significantly increase ldh release. morphological changes in hela cells on treatment with icd-85 compared with untreated hela cells consistent with an apoptotic mechanism of cell death, such as cell shrinkage which finally results in the generation of apoptotic bodies. however, when mrc-5 cells were exposed to icd-85, no significant changes in cell morphology and ldh were observed at concentrations below 2.6×10µg/ml. also, the apoptosis-induction mechanism by icd-85 on hela cells was found through activation of caspase-8 and the activity of caspase-8 in hela cells was 1.5 folds more than its activity on mrc-5 cells. conclusion: therefore, the apoptosis-induced mechanisms by icd-85 are through activation of caspase-8 and concerning the least cytotoxic effect on mrc-5 cells, icd-85 may be used as anticancer compound to inhibit growth of cancer cells.
similar resources
Extracellular Caspase-8 Dependent Apoptosis on HeLa Cancer Cells and MRC-5 Normal Cells by ICD-85 (Venom Derived Peptides)
BACKGROUND Our previous studies revealed an inhibitory effect of ICD-85 (venom derived peptides) on MDA-MB231 and HL-60 cell lines, through induction of apoptosis. The purpose of this study was to investigate apoptosis-induced mechanism on HeLa and MRC-5 cells by ICD-85 through activation of caspase-8. METHODS Cell viability, cytosolic enzyme Lactate Dehydrogenase (LDH) and cell morphology we...
full textCytotoxicity of ICD-85 NPs on Human Cervical Carcinoma HeLa Cells through Caspase-8 Mediated Pathway
The biological application of nanoparticles (NPs) is a rapidly developing area of nanotechnology that raises new possibilities in the treatment of human cancers. The cytotoxicity was evaluated by MTT and LDH assays. The apoptotic effect of free ICD-85 and ICD-85 NPs on HeLa cells was assessed using caspase-8 colorimetric assay. The MTT assay showed that ICD-85 NPs could enhance the in-vitro cyt...
full textCytotoxicity of ICD-85 NPs on Human Cervical Carcinoma HeLa Cells through Caspase-8 Mediated Pathway
The biological application of nanoparticles (NPs) is a rapidly developing area of nanotechnology that raises new possibilities in the treatment of human cancers. The cytotoxicity was evaluated by MTT and LDH assays. The apoptotic effect of free ICD-85 and ICD-85 NPs on HeLa cells was assessed using caspase-8 colorimetric assay. The MTT assay showed that ICD-85 NPs could enhance the in-vitro cyt...
full textInduction of Apoptosis in Human Leukemia Cell Line (HL60) by Animal’s Venom Derived Peptides (ICD-85)
Our previous studies revealed an inhibitory effect of ICD-85 (Venom derived peptides) on breast cancer cell line MDA-MB231. ICD-85 was also confirmed by in-vivo studies to suppress the breast tumor in mice. However, the exact mechanism of ICD-85 was unknown. Hence, the present study was undertaken to assess the mechanism of ICD-85 effect as an anti-proliferative agent of cancer cells. The effec...
full textInduction of Apoptosis in Human Leukemia Cell Line (HL60) by Animal’s Venom Derived Peptides (ICD-85)
Our previous studies revealed an inhibitory effect of ICD-85 (Venom derived peptides) on breast cancer cell line MDA-MB231. ICD-85 was also confirmed by in-vivo studies to suppress the breast tumor in mice. However, the exact mechanism of ICD-85 was unknown. Hence, the present study was undertaken to assess the mechanism of ICD-85 effect as an anti-proliferative agent of cancer cells. The effec...
full textThe anti-tumor efficacy of nanoparticulate form of ICD-85 versus free form
Biodegradable polymeric nanoparticles (NPs) have been intensively studied as a possible way to enhance anti-tumor efficacy while reducing side effects. ICD-85, derived from the venom of two separate species of venomous animals, has been shown to exhibit anti-cancer activity. In this report polymer based sodium alginate nanoparticles of ICD-85 was used to enhance its therapeutic effects and redu...
full textMy Resources
Save resource for easier access later
Journal title:
iranian journal of cancer preventionجلد ۵، شماره ۴، صفحات ۱۹۴-۲۰۲
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023